A 2025 Bayesian network meta-analysis of 48 RCTs covering 27,729 participants compared GI adverse events across the major GLP-1 RAs.[1] Tirzepatide showed the highest risk of nausea and diarrhea among the agents studied
Semaglutide and tirzepatide accelerate weight loss by: Delaying the emptying of the stomach, leading to a feeling of fullness Slowing the contraction of muscles that propel food in the gastrointestinal tract Lowering blood sugars Stimulating the secretion of insulin by the pancreas What Are Common Side Effects
Your reduced appetite means every meal needs to be nutrient-dense
Peptides are short chains of amino acids think of them as biological signals
Retrieved from Hollstein, T., Heinitz, S., Ando, T., et al
Improved Digestive & Organ Health: BPC-157 protects the gastrointestinal lining, aiding recovery from ulcers or inflammation, while TB-500 promotes organ health through improved circulation